Melanoma Patients Have Another Hope With New Orphan Drug Designation (ADH, MEDX)
Adherex Technologies Inc. (AMEX: ADH) has announced that it has received an orphan drug designation for its ADH-1 from the FDA for the use of ADH-1 in conjunction with melphalan ...Read Full Story »

